Literature DB >> 17171512

Intra-individual comparison of image contrast in SPIO-enhanced liver MRI at 1.5T and 3.0T.

Marcus von Falkenhausen1, Carsten Meyer, Götz Lutterbey, Nuschin Morakkabati, Oliver Walter, Jürgen Gieseke, Renate Blömer, Winfried A Willinek, Christiane K Kuhl, Hans H Schild.   

Abstract

The purpose of the study was to examine if the higher susceptibility at 3.0 Tesla (T) compared to 1.5 T will affect the contrast in MR imaging of the liver after application of superparamagnetic iron oxide particles (SPIO). The study was approved by our institutional review board and informed consent was obtained. Seventeen healthy volunteers were examined in a prospective, intra-individual comparative study within one day on a 1.5 T and a 3.0 T MRI system. T2 weighted TSE sequences were acquired after bolus injection of a SPIO contrast agent. Image contrast and signal to noise ratio (SNR) were compared between the field strengths. Image contrast was calculated between the liver tissue and the kidneys / spleen / muscles and fluids. The students'T-test was used for statistical analysis. No influence of the higher field strength could be observed on image contrast except for the liver / muscle contrast. This was due to a distinct SNR increase of the muscle tissue at 3.0 T as a result of their relaxation properties. The higher susceptibility at 3.0 T compared to 1.5 T does not translate into a stronger signal attenuation of the SPIO enhanced liver parenchyma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17171512     DOI: 10.1007/s00330-006-0484-y

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  15 in total

1.  Time-of-flight MR angiography: comparison of 3.0-T imaging and 1.5-T imaging--initial experience.

Authors:  Winfried A Willinek; Markus Born; Birgit Simon; Henriette J Tschampa; Carsten Krautmacher; Jurgen Gieseke; Horst Urbach; Hans J Textor; Hans H Schild
Journal:  Radiology       Date:  2003-12       Impact factor: 11.105

2.  Clinical experience on 3.0 T systems in Niigata, 1996 to 2002.

Authors:  Tsutomu Nakada
Journal:  Invest Radiol       Date:  2003-07       Impact factor: 6.016

3.  MR imaging relaxation times of abdominal and pelvic tissues measured in vivo at 3.0 T: preliminary results.

Authors:  Cedric M J de Bazelaire; Guillaume D Duhamel; Neil M Rofsky; David C Alsop
Journal:  Radiology       Date:  2004-03       Impact factor: 11.105

4.  Clinical results with Resovist: a phase 2 clinical trial.

Authors:  P Reimer; E J Rummeny; H E Daldrup; T Balzer; B Tombach; T Berns; P E Peters
Journal:  Radiology       Date:  1995-05       Impact factor: 11.105

5.  Hepatic lesion detection and characterization: value of nonenhanced MR imaging, superparamagnetic iron oxide-enhanced MR imaging, and spiral CT-ROC analysis.

Authors:  P Reimer; N Jähnke; M Fiebich; W Schima; F Deckers; C Marx; N Holzknecht; S Saini
Journal:  Radiology       Date:  2000-10       Impact factor: 11.105

6.  MRI of the pelvis at 3 T: very high spatial resolution with sensitivity encoding and flip-angle sweep technique in clinically acceptable scan time.

Authors:  Nuschin Morakkabati-Spitz; Jürgen Gieseke; Christiane Kuhl; Götz Lutterbey; Marcus von Falkenhausen; Frank Träber; Tjoung-Won Park-Simon; Oliver Zivanovic; Hans H Schild
Journal:  Eur Radiol       Date:  2005-10-14       Impact factor: 5.315

Review 7.  Superparamagnetic iron oxide contrast agents: physicochemical characteristics and applications in MR imaging.

Authors:  Y X Wang; S M Hussain; G P Krestin
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

Review 8.  Hepatic MRI with SPIO: detection and characterization of focal liver lesions.

Authors:  P Reimer; B Tombach
Journal:  Eur Radiol       Date:  1998       Impact factor: 5.315

9.  [Use of SPIO-enhanced T1- and T2-weighted images for the differentiation of liver lesions: an ROC analysis].

Authors:  C Stroszczynski; G Gaffke; S Gretschel; A Rambow; D Jost; I Schlecht; U Schneider; B Schicke; P Hohenberger; B Gebauer; R Felix
Journal:  Rofo       Date:  2003-10

Review 10.  Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications.

Authors:  Peter Reimer; Thomas Balzer
Journal:  Eur Radiol       Date:  2002-11-01       Impact factor: 5.315

View more
  5 in total

1.  Renal imaging at 7 Tesla: preliminary results.

Authors:  Lale Umutlu; Stephan Orzada; Sonja Kinner; Stefan Maderwald; Irina Brote; Andreas K Bitz; Oliver Kraff; Susanne C Ladd; Gerald Antoch; Mark E Ladd; Harald H Quick; Thomas C Lauenstein
Journal:  Eur Radiol       Date:  2010-09-25       Impact factor: 5.315

2.  Detection of hepatic metastases by superparamagnetic iron oxide-enhanced MR imaging: prospective comparison between 1.5-T and 3.0-T images in the same patients.

Authors:  Keitaro Sofue; Masakatsu Tsurusaki; Mototaka Miyake; Aine Sakurada; Yasuaki Arai; Kazuro Sugimura
Journal:  Eur Radiol       Date:  2010-04-29       Impact factor: 5.315

3.  Renal imaging at 5 T versus 3 T: a comparison study.

Authors:  Liyun Zheng; Chun Yang; Ruofan Sheng; Yongming Dai; Mengsu Zeng
Journal:  Insights Imaging       Date:  2022-09-24

4.  Comparison of CT and MRI in Diagnosis of Laryngeal Carcinoma with Anterior Vocal Commissure Involvement.

Authors:  Jian-Hui Wu; Jing Zhao; Zeng-Hong Li; Wei-Qiang Yang; Qi-Hong Liu; Zhi-Yun Yang; Bing Liao; Xiao-Ling Li; Bin Wang; Hao Qin; Jie Luo; Ke-Xing Lv; Wei-Ping Wen; Wen-Bin Lei
Journal:  Sci Rep       Date:  2016-08-02       Impact factor: 4.379

5.  1.5 versus 3 versus 7 Tesla in abdominal MRI: A comparative study.

Authors:  Anja Laader; Karsten Beiderwellen; Oliver Kraff; Stefan Maderwald; Karsten Wrede; Mark E Ladd; Thomas C Lauenstein; Michael Forsting; Harald H Quick; Kai Nassenstein; Lale Umutlu
Journal:  PLoS One       Date:  2017-11-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.